This review covers article and patent data obtained mostly within the period 2013–2024 on the synthesis and biological activity of quinazolines a-annelated by five-membered heterocycles. Pyrrolo-, (iso)indolo-, pyrazolo-, indazolo-, (benz)imidazo-, (benz)thiazolo-, and triazolo- aquinazoline systems have shown multiple potential activities against numerous targets. We highlight that most research efforts are directed to design of anticancer, antibacterial, anti-inflammatory, and other agents of azoloaquinazoline nature. This review emphases both the medicinal chemistry aspects of pyrroloa-, (iso)indoloa-, and azoloaquinazolines and the comprehensive synthetic strategies of quinazolines annelated at the N(1)–C(2) bond from the perspective of drug development and discovery.
Lipunova et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: